Skip to main content

Dexcom G7

By Adam Ang | 02:55 am | June 23, 2023
The CGM-based service will begin in Q4. 
By Emily Olsen | 11:54 am | December 13, 2022
The company said it plans to launch the latest model of its CGM in early 2023.
By Laura Lovett | 02:57 pm | January 13, 2022
The company also unveiled its 2021 revenue. 
By Mallory Hackett | 01:02 pm | February 12, 2021
The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.   
By Mallory Hackett | 01:44 pm | July 31, 2020
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
By Laura Lovett | 05:00 pm | June 19, 2020
The executives also share details about what patients can expect from the G7 next year. 
By Jonah Comstock | 04:43 pm | February 20, 2020
Both CGM competitors announced integrations with Insulet yesterday during the Advanced Technologies & Treatment for Diabetes Congress in Madrid.
By Jonah Comstock | 10:49 am | January 21, 2020
Dexcom CEO Kevin Sayer has seen the company through some boom years, including growth that has outpaced the company's manufacturing capabilities. But they've learned lessons and are pressing on with a new, smaller sensor in 2021.